在现代免疫抑制治疗下，急性排斥降到最低；然而，病人和长期的同种异体移植物生存并没有同时得到改善。
Acute rejection has been minimised under modern immunosuppression; however, patient and long-term allograft outcomes have not improved concurrently.
我将移植的一些幸存者，并从他们生根大量削减对未来的植物。他们必须非常强壮，或将无法生存。
I will be transplanting some of the survivors and rooting numerous cutting from them for future plants. They have to be very hardy or would not have survived.
必须使用的移植物在两天的维持生存。
The grafts must be used within a couple of days to maintain viability.
观察异种移植物的生存时间。
然而，有一点似乎很清楚，就是卵巢组织的移植物的生存期不长。
However, it seems clear that the ovarian tissue graft has a shortened life span.
比较各组移植物的体积，生长抑制率及动物生存时间。
The tumor volume and the tumor growth inhibition rate were assayed.
移植物和患者的生存率与ANCA相关性血管炎的患者相比，那些在非糖尿病患者中观察到。
Graft and patient survival rates among patients with ANCA-associated vasculitis are comparable to those observed in nondiabetic patients.
现在已经很清楚，新发糖尿病和糖尿病前期状态(空腹血糖受损和糖耐量受损)的负面影响移植后的移植物和患者的生存。
It has become clear that both new-onset diabetes and prediabetic states (impaired fasting glucose and impaired glucose tolerance) negatively influence graft and patient survival after transplantation.
现在已经很清楚，新发糖尿病和糖尿病前期状态(空腹血糖受损和糖耐量受损)的负面影响移植后的移植物和患者的生存。
It has become clear that both new-onset diabetes and prediabetic states (impaired fasting glucose and impaired glucose tolerance) negatively influence graft and patient survival after transplantation.
应用推荐